CureLGMD2i Foundation - BridgeBio Reports Positive Phase 3 Results for Small Molecule BBP-418 in LGMD2I/R9 FORTIFY Study

Name: CureLGMD2i Foundation - BridgeBio Reports Positive Phase 3 Results for Small Molecule BBP-418 in LGMD2I/R9 FORTIFY Study
Start: 2025-10-29T13:27:34+00:00
Location: See link for location

Excellent news for our LGMD2I/R9 family! Link to GlobeNewswire’s article.

https://curelgmd2i.com/2025/10/29/bridgebio-reports-positive-phase-3-results-for-small-molecule-bbp-418-in-lgmd2i-r9-fortify-study/

Event details
When: Oct 29, 2025 1:27 PM
Where: See link for location

Join the conversation on Tappet